Myostatin inactivation increases myotube size through regulation of translational initiation machinery
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Myostatin deficiency leads in skeletal muscle overgrowth but the precise molecular mechanisms underlying this hypertrophy are not well understood. In this study, to gain insight into the role of endogenous myostatin in the translational regulation, we used an in vitro model of cultured satellite cells derived from myostatin knock-out mice. Our results show that myostatin knock-out myotubes are larger than control myotubes and that this phenotype is associated with an increased activation of the Akt/mTOR signaling pathway, a known regulator of muscle hypertrophy. These results demonstrate that hypertrophy due to myostatin deficiency is preserved in vitro and suggest that myostatin deletion results in an increased protein synthesis. Accordingly, the rates of global RNA content, polysome formation and protein synthesis are all increased in myostatin-deficient myotubes while they are counteracted by the addition of recombinant myostatin. We furthermore demonstrated that genetic deletion of myostatin stimulates cap-dependent translation by positively regulating assembly of the translation preinitiation complex. Together the data indicate that myostatin controls muscle hypertrophy in part by regulating protein synthesis initiation rates, that is, translational efficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583 · cited 1×
“Extensive investigations pinpoint the central role of Akt/mTOR signaling pathway for both in vitro and in vivo skeletal muscle growth [Bodine et al., 2001; Rommel et al., 2001].”
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556 · cited 2×
“…mutations as well as experimental knock-out of themyostatin gene lead to a hypermuscular phenotype in mice, sheep, dogs, cattle, and human [Grobet et al., 1997; Kambadur et al., 1997; McPherron et al., 1997; Schuelke et al., 2004; Clop et al., 2006; Mosher et al., 2007] resulting from…”
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204 · cited 2×
“…well as experimental knock-out of themyostatin gene lead to a hypermuscular phenotype in mice, sheep, dogs, cattle, and human [Grobet et al., 1997; Kambadur et al., 1997; McPherron et al., 1997; Schuelke et al., 2004; Clop et al., 2006; Mosher et al., 2007] resulting from both hypertrophy and…”
Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826 · cited 2×
“…experimental knock-out of themyostatin gene lead to a hypermuscular phenotype in mice, sheep, dogs, cattle, and human [Grobet et al., 1997; Kambadur et al., 1997; McPherron et al., 1997; Schuelke et al., 2004; Clop et al., 2006; Mosher et al., 2007] resulting from both hypertrophy and hyperplasia.”
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784 · cited 1×
“Myostatin can inhibit the activation and self renewal of satellite cells [McCroskery et al., 2003].”
Smad2 and 3 transcription factors control muscle mass in adulthood
Sartori, R., Milan, G., Patron, M., Mammucari, C., Blaauw, B., Abraham, R., & Sandri, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2009 · Cited by 517 · cited 2×
“Transfection of a dominant negative myostatin receptor into adult skeletal muscle leads to an increase of muscle mass associated with increased phosphorylation of S6 a downstream effectors of Akt in the mTOR pathway [Sartori et al., 2009].”
Cited by
Glucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397
“guanosine cap binding complexes more efficiently in Mstn cells than in control cells, whereas myostatin addition inhibits this process [57].”
BackgroundInfluentialSelf-citationSubstantial skeletal muscle loss occurs during only 5 days of disuse
Wall, B. T., Dirks, M. L., Snijders, T., Senden, J. M. G., Dolmans, J., & van Loon, L. J. C. (2014) · Acta Physiologica · doi:10.1111/apha.12190 · Cited by 346
TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease
Sartori, R., Gregorevic, P., & Sandri, M. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.002 · Cited by 177
Protein breakdown in cancer cachexia
Sandri, M. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.11.002 · Cited by 134
“It has been established by different groups that muscle hypertrophy induced by Myostatin inhibition is mediated by an increase of protein synthesis that utilizes signaling via Akt/mTOR axis [141, 142, 144, 146-149], as rapamycin treatment (to inhibit mTOR) or mTOR knockdown reduces the hypertrophic effect of Myostatin…”
BackgroundWall, B. T., Burd, N. A., Franssen, R., Gorissen, S. H. M., Snijders, T., Senden, J. M., Gijsen, A. P., & van Loon, L. J. C. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00325.2016 · Cited by 34
New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass
Goodman, C. A., & Hornberger, T. A. (2014) · F1000Prime Reports · doi:10.12703/p6-20 · Cited by 30
“Other studies have also shown that increased myostatin is sufficient to induce a decrease in protein synthesis, possibly by promoting the atrogin-1-mediated degradation of ribosomal proteins and translation initiation factors or via the inhibition of signaling through the protein kinase B (Akt) and mechanistic target…”
Background
Metadata
- Authors
- Rodriguez, J., Vernus, B., Toubiana, M., Jublanc, E., Tintignac, L., Leibovitch, S., & Bonnieu, A.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2011-10-22
- Volume
- 112
- Issue
- 12
- Pages
- 3531-3542
- ISSN
- 0730-2312 (ISSN-L)
- OpenAlex
- W2073449316
- Cited by
- 44
- References
- 12
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.